Affective changes with estrogen and androgen replacement theraphy in surgically menopausal women☆
References (46)
- et al.
Is the menopausal age rapidly changing?
Maturitas
(1979) - et al.
The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical lipid and hormonal results
Maturitas
(1984) Adrenal and gonadal secretion in normal females
- et al.
Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain
Brain Res.
(1975) - et al.
The metabolism of androgen in central neuroendocrine tissues
J. Steroid. Biochem.
(1975) - et al.
Hypothalamo-pituitary-gonadal function in primary endogenously depressed men: preliminary findings
- et al.
Sex steroids and affect in the surgical menopause: a double-blind, cross over study
Psychoneuroendocrinology
(1985) - et al.
Postmenopausal estrogen and androgen replacement and lipoprotein lipid concentrations
Am. J. Obstet. Gynecol.
(1987) Plasma tryptophan levels and mental depression in postmenopausal subjects: effects of oral piperazine-oestrone sulphate
IRCS Med. Sci.
(1973)Estrogens, plasma trypophan levels in perimenopausal patients
Involutional melancholia revisited
Am. J. Psychiatry
(1984)
Endocrine changes and symptomatology after oophorectomy in premenopausal women
Br. J. Obstet. Gynaecol.
(1977)
Is oestrogen therapy effective in the treatment of menopausal depression?
J.R. Coll. Gen. Pract.
(1981)
Hormone therapy and affect
Maturitas
(1979)
Eysenck Personality Inventory Manual
(1958)
Effects of exogenous estrogens on minor psychiatric symptoms in postmenopausal women
S. Afr. Med. J.
(1973)
Manual of the General Health Questionnaire
(1978)
Anabolic steroids: effects on strength development
Science
(1969)
Endocrine and clinical effect of estradiol and testosterone pellets used in long-term replacement therapy
Int. J. Gynec. Obstet.
(1982)
Estrogen therapy for severe persistent depression in women
Arch. Gen. Psychiatry
(1979)
Short marital adjustment and prediction tests
Marr. Fam. Liv.
(1969)
Manual for the Profile of Mood States
Cited by (245)
Supplementation with d-chiro-inositol in women
2023, A Clinical Guide to InositolsCentering the Needs of Transgender, Nonbinary, and Gender-Diverse Populations in Neuroendocrine Models of Gender-Affirming Hormone Therapy
2022, Biological Psychiatry: Cognitive Neuroscience and NeuroimagingCitation Excerpt :Conversely, venlafaxine efficacy in cisgender menopausal women is impaired by E2 (80). Studies on the efficacy of estrogen supplementation on negative affect reported mixed results in postmenopausal cisgender women (81,82). Nevertheless, clinical studies considering mood in the context of endogenous hormonal changes during menopause and pregnancy cannot control for co-occurring psychosocial stressors, sleep deprivation, and body image concerns.
Chronic aromatase inhibition increases ventral hippocampal neurogenesis in middle-aged female mice
2019, PsychoneuroendocrinologyMenopause and Aging
2019, Yen & Jaffe's Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management: Eighth EditionEFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease
2017, Journal of Lipid Research
- ☆
This study was supported by Grant No. MA-8707 from The Medical Research Council of Canada awarded to B.B. Sherwin.
Copyright © 1988 Published by Elsevier B.V.